Abstract:
The present invention relates to a polypeptide, which is specifically bound to Annexin A1 to inhibit function, and uses thereof. More specifically, in the present invention, provided is a pharmaceutical composition for preventing, treating and/or diagnosing diseases, which includes polypeptide bound to Annexin A1; an antagonist for the Annexin A1 including the polypeptide; the specific antibody of Annexin A1 or a piece bound to antigen thereof including the polypeptide; and the antagonist and/or the antibody or the antibody or pieces bound to antigen thereof as active ingredients.
Abstract:
본 발명은 반도체 칩 테스트용 커넥팅 유닛을 제공한다. 상기 반도체 칩 테스트용 커넥팅 유닛은 일정의 패턴의 전기적 접속 단자들을 갖는 반도체 칩이 안착되며, 다수의 홀들이 형성되는 다수의 커넥터들과, 상기 전기적 접속 단자들을 외부로 통전 시키는 케이블들과, 상기 케이블들을 상기 홀들을 통하여 상기 전기적 접속 단자들과 선택적으로 연결시키는 결합부를 포함한다. 또한, 본 발명은 상기 반도체 칩 테스트용 커넥팅 유닛 및 이를 갖는 반도체 칩 테스트 장치도 제공함으로써, 양한 패턴의 전기적 접속 단자들을 갖는 반도체 칩들에 대하여 전기적 테스트를 수행함과 아울러 반도체 칩들을 트레이에 한 번에 수납시키도록 할 수 있다.
Abstract:
The present invention relates to a fusion protein having an annexin A2 binding protein, a p53 protein, and a p18 protein bound, and to a pharmaceutical composition including the fusion protein for preventing or treating a cancer. Provided in an embodiment of the present invention is a fusion protein including an annexin A2 binding protein, a p53 protein or a fragment of the same, and a p18 protein. The fusion protein can additionally include one or more selected from the group consisting of an in vitro stabilization protein, a membrane transfer sequence (MTS) domain, a nucleus-cytoplasm signal domain, ATT, and STOPx2.
Abstract:
The present invention relates to a composition for treating or preventing cancers. More specifically, the present invention relates to a fusion protein bound to annexin a1 binding protein, p53 protein, and p18 protein or p16 protein; a manufacturing of the fusion protein; and a composition for treating and preventing cancers including the fusion protein. In the present invention, the fusion protein comprises at least one polypeptide selected from a group consisting of in vitro stabilization protein, a membrane transfer sequence domain (MTS), a nucleus-cytoplasm signal domain and in vivo stabilization protein.
Abstract:
A non-volatile multi-level cell memory system and an adaptive data back-up method in the system are disclosed. The adaptive data back-up method comprises steps of receiving a write request from a host and determining a size of data (size of back-up data) which needs back-up among the data of write request; selecting one of more than two different back-up types based on the size of data which needs back-up; carrying out back-up according to the selected back-up type.